Swanbridge Capital is a Rotterdam based venture capital fund that actively invests in young, high potential companies in the life sciences. We focus on companies that are in very early stage in their development of therapeutics, diagnostics and medical devices. Our team is committed to actively support our portfolio companies in their quest for success.

Latest News

Abegaill B.V. announces the successfully closing of a seed funding round provided by Swanbridge Capital and Leander Healthcare.

Read more

Meet us at

Innovation for Health

1 February РRotterdam

Read more
Swanbridge Capital
Rotterdam Science Tower
Marconistraat 16
3029 AK Rotterdam

© 2016 Swanbridge Capital
Get Started Online